ARTV vs DVA · $37.3M cap vs P/E 14, rev $6.97B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
ARTV currently screens at market cap $37.3M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the ARTV and DVA stock pages for the full models.
Not investment advice.